Moore RD - Search Results

1

Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population.

Edwards JK, Cole SR, Breger TL, Filiatreau LM, Zalla L, Mulholland GE, Horberg MA, Silverberg MJ, John Gill M, Rebeiro PF, Thorne JE, Kasaie P, Marconi VC, Sterling TR, Althoff KN, Moore RD, Eron JJ. Edwards JK, et al. Among authors: moore rd. Clin Infect Dis. 2022 Sep 14;75(5):867-874. doi: 10.1093/cid/ciab1030. Clin Infect Dis. 2022. PMID: 34983066 Free PMC article.

2

A comprehensive plan for managed care of patients infected with human immunodeficiency virus.

Bartlett JG, Moore R. Bartlett JG, et al. Clin Infect Dis. 1999 Jul;29(1):50-5. doi: 10.1086/520179. Clin Infect Dis. 1999. PMID: 10433564

3

Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort.

Perez JL, Moore RD. Perez JL, et al. Among authors: moore rd. Clin Infect Dis. 2003 Jan 15;36(2):212-8. doi: 10.1086/345669. Epub 2003 Jan 6. Clin Infect Dis. 2003. PMID: 12522755

4

Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity.

Sterling TR, Chaisson RE, Moore RD. Sterling TR, et al. Among authors: moore rd. Clin Infect Dis. 2003 Mar 15;36(6):812-5. doi: 10.1086/367934. Epub 2003 Feb 27. Clin Infect Dis. 2003. PMID: 12627368

5

Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.

Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Sethi AK, et al. Among authors: moore rd. Clin Infect Dis. 2003 Oct 15;37(8):1112-8. doi: 10.1086/378301. Epub 2003 Sep 19. Clin Infect Dis. 2003. PMID: 14523777

6

Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.

Sterling TR, Chaisson RE, Keruly J, Moore RD. Sterling TR, et al. Among authors: moore rd. J Infect Dis. 2003 Dec 1;188(11):1659-65. doi: 10.1086/379741. Epub 2003 Nov 14. J Infect Dis. 2003. PMID: 14639536

7

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.

Lucas GM, Weidle PJ, Hader S, Moore RD. Lucas GM, et al. Among authors: moore rd. Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S409-13. doi: 10.1086/421405. Clin Infect Dis. 2004. PMID: 15156431 Clinical Trial.

8

Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.

Karakousis PC, Moore RD, Chaisson RE. Karakousis PC, et al. Among authors: moore rd. Lancet Infect Dis. 2004 Sep;4(9):557-65. doi: 10.1016/S1473-3099(04)01130-2. Lancet Infect Dis. 2004. PMID: 15336223 Review.

9

Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.

Nettles RE, Kieffer TL, Simmons RP, Cofrancesco J Jr, Moore RD, Gallant JE, Persaud D, Siliciano RF. Nettles RE, et al. Among authors: moore rd. Clin Infect Dis. 2004 Oct 1;39(7):1030-7. doi: 10.1086/423388. Epub 2004 Sep 1. Clin Infect Dis. 2004. PMID: 15472857

10

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS. Mehta SH, et al. Among authors: moore rd. Hepatology. 2005 Jan;41(1):123-31. doi: 10.1002/hep.20541. Hepatology. 2005. PMID: 15619237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

931 results

Search Page

Filters